Elevation of Hepatic Transaminases after Enoxaparin Use: Case Report and Review of Unfractionated and Low-Molecular-Weight Heparin-Induced Hepatotoxicity
- 1 January 2001
- journal article
- case report
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 21 (1) , 108-113
- https://doi.org/10.1592/phco.21.1.108.34436
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Heparin-Induced Increase in Serum Levels of AminotransferasesActa Medica Scandinavica, 2009
- A Meta-analysis Comparing Low-Molecular-Weight Heparins With Unfractionated Heparin in the Treatment of Venous ThromboembolismArchives of internal medicine (1960), 2000
- Transaminase Elevation in Patients Treated with Unfractionated Heparin or Low Molecular Weight Heparin for Venous ThromboembolismClinical and Applied Thrombosis/hemostasis, 1998
- Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.Journal of Bone and Joint Surgery, 1994
- Biologic Tolerance of Two Different Low Molecular Weight HeparinsSeminars in Thrombosis and Hemostasis, 1991
- Adverse effects of three different forms of heparin therapy: thrombocytopenia, increased transaminases, and hyperkalaemiaEuropean Journal of Clinical Pharmacology, 1989
- Modifications of Liver Enzymes During Heparin TherapyActa Clinica Belgica, 1986
- Transaminase Elevations in Patients Receiving Bovine or Porcine HeparinAnnals of Internal Medicine, 1984
- Serum Aminotransferases after Low‐Dose Heparin TreatmentActa Medica Scandinavica, 1978
- Hyper-transaminasemia with heparin therapy.BMJ, 1975